Sharekhan

Indraprastha Medical Corporation Ltd

Wed 11/06/2025,15:57:53 | NSE : INDRAMEDCO

₹ 419.20-3.10 (-0.73%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 424.95

Previous Close

₹ 422.30

Volume

96288

Mkt Cap ( Rs. Cr)

₹3842.93

High

₹ 427.00

Low

₹ 416.15

52 Week High

₹ 572.00

52 Week Low

₹ 232.50

Book Value Per Share

₹ 57.21

Dividend Yield

1.06

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Indraprastha Medical Corporation Ltd

Your Vote -

Buy

61.90%

Hold

33.33%

Sell

4.76%

61.90%

42 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

419.20

127

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

127

Option Chain

Analyzes market sentiment, predicts Indraprastha Medical Corporation Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Indraprastha Med - Change in Director(s)

    26 May 2025, 1:25PM Indraprastha Medical Corporation Limited has informed the Exchange regarding Change in Director(s) of the company.
  • Indraprastha Med - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    26 May 2025, 1:04PM INDRAPRASTHA MEDICAL CORPORATION LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ S
  • Indraprastha Med - Announcement under Regulation 30 (LODR)-Change in Directorate

    26 May 2025, 12:57PM we wish to inform you that Dr. Arum Rai ( DIN: 07159822) has completed his second five year term as Independent director in the company, on 25th May,
  • Indraprastha Med - Change in Director(s)

    23 May 2025, 11:16AM Indraprastha Medical Corporation Limited has informed the Exchange regarding Change in Director(s) of the company.
  • Indraprastha Med - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    23 May 2025, 11:09AM INDRAPRASTHA MEDICAL CORPORATION LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ S
  • Indraprastha Med - Announcement under Regulation 30 (LODR)-Change in Directorate

    23 May 2025, 11:04AM we hereby inform you that Dr Menaka Guruswamy ( DIN 08742679) has completed her tenure viz. first term of five (5) consecutive years on 22nd May, 202
  • Indraprastha Med - Outcome of Board Meeting-XBRL

    16 May 2025, 6:27PM INDRAPRASTHA MEDICAL CORPORATION LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 16-May-2025 for Dividend
  • Indraprastha Med - Dividend

    16 May 2025, 6:23PM Indraprastha Medical Corporation Limited has informed the Exchange that Board of Directors at its meeting held on May 16, 2025, recommended Final Divi
  • Indraprastha Med Q4 net profit up 31.57% at Rs 41.01 cr

    16 May 2025, 6:20PM The company reported standalone net profit of Rs 41.01 crore for the quarter ended March 31, 2025 as compared to Rs 31.17 crore in the same period las
  • Indraprastha Med - Dividend

    16 May 2025, 6:20PM Indraprastha Medical Corporation Limited has informed the Exchange that Board of Directors at its meeting held on May 16, 2025, recommended Final Divi
  • Indraprastha Med - Outcome of Board Meeting

    16 May 2025, 6:16PM Indraprastha Medical Corporation Limited has informed the Exchange regarding Outcome of Board Meeting held on May 16, 2025.
  • Indraprastha Med - Board Meeting Outcome for Outcome Of Board Meeting

    16 May 2025, 5:53PM This is to inform you that the Board of Directors of the company has, at its meeting held on Friday, 16th May, 2025 (i.e., Today), inter-alia:\r\n\r\n
  • Indraprastha Med - Board Meeting Intimation

    5 May 2025, 11:33AM INDRAPRASTHA MEDICAL CORPORATION LIMITED has informed the Exchange about Board Meeting to be held on 16-May-2025 to consider and approve the Yearly Au
  • Indraprastha Med - Board Meeting Intimation for Board Meeting On 16Th May, 2025

    5 May 2025, 11:27AM Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 ,inter alia,
  • Indraprastha Med - Credit Rating

    28 Apr 2025, 1:00PM Indraprastha Medical Corporation Limited has informed the Exchange about Credit Rating
  • Indraprastha Med - Announcement under Regulation 30 (LODR)-Credit Rating

    28 Apr 2025, 12:53PM we wish to inform that ICRA Limited has:\r\na) reaffirmed long-term - fund based - cash credit rating of ICRAAA (pronounced ICRA Double A) for Rs. 32.
  • Indraprastha Med - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    28 Apr 2025, 12:45PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Indraprastha Med has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    11 Apr 2025, 12:10PM As of March 2025, 51.00% is owned by Promoters and 49.00% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 49.39% and Fore
  • Indraprastha Med - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Apr 2025, 3:56PM Indraprastha Medical Corporation Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Indraprastha Med - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Apr 2025, 1:32PM Enclosed please find herewith, a certificate dated 02-04-2025, issued by RTA of the company for the quarter ended 31-03-2025.. this is for your inform
  • Indraprastha Med - Trading Window

    24 Mar 2025, 5:29PM Indraprastha Medical Corporation Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tradi
  • Indraprastha Med - Trading Window-XBRL

    24 Mar 2025, 12:47PM INDRAPRASTHA MEDICAL CORPORATION LIMITED has informed the Exchange about Closure of Trading Window
  • Indraprastha Medical Corp

    3 Apr 2023 , 1:20PM ICRA reaffirms Indraprastha Medical Corporation Ltd.’s credit ratings to AA stable due to improving operating metrics and earnings along with strong credit metrics. Positive for the stock.

Key fundamentals

Evaluate the intrinsic value of Indraprastha Medical Corporation Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 596.68 477.76 379.45 325.44 272.756
Liabilities 596.68 477.76 379.45 325.44 272.756
Equity 91.67 91.67 91.67 91.67 91.673
Gross Profit 244.27 193.36 150.7 114.3 40.27
Net Profit 160.99 123.96 86.15 58.62 2.329
Cash From Operating Activities 156.75 200.15 144.47 71.29 27.898
NPM(%) 11.86 9.95 7.84 6.6 0.37
Revenue 1356.36 1244.7 1098.67 888.16 613.382
Expenses 1112.09 1051.34 947.97 773.86 573.112
ROE(%) 30.69 23.63 16.42 11.17 0.44

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
4.5 45 1.07 440.25
13 Sep 2024 4.5 45 1.07 264.25
15 Sep 2023 3 30 1.07 84.35
15 Sep 2022 2.5 25 1.07 58.4
12 Sep 2019 1.6 16 1.07 38.1
12 Sep 2018 1.5 15 1.07 48.25
14 Sep 2017 1.8 18 1.07 54.2
18 Aug 2016 1.8 18 1.07 52.45
16 Sep 2015 1.8 18 1.07 55.85
18 Sep 2014 1.8 18 1.07 42.75
19 Sep 2013 1.6 16 1.07 35.1
06 Sep 2012 1.6 16 1.07 33.5
05 Sep 2011 1.6 16 1.07 35.9
30 Aug 2010 1.6 16 1.07 48.85
27 Aug 2009 1.5 15 1.07 29.55
28 Aug 2008 1.4 14 1.07 29.75
07 Sep 2007 1.25 12.5 1.07 32.65
28 Jul 2006 1.25 12.5 1.07 32.95
18 Aug 2005 1 10 1.07 35.6
18 Aug 2004 1 10 1.07 18.1
06 Sep 2002 0 7.5 1.07 16.8
0 0 1.07 15.4
0 7.5 1.07 21.95
0 0 1.07 8

Peers

Other companies within the same industry or sector that are comparable to Indraprastha Medical Corporation Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 855.40 0.52 28.38 241.02 301.39 0.58
Lotus Eye Hospital and Institute Ltd 72.06 -1.95 205.89 878.23 3.55 0.00
Vaishali Pharma Ltd 12.58 -2.25 209.67 452.67 3.13 0.00
Astec Lifesciences Ltd 808.70 -0.33 0.00 828.09 -687.10 0.00

Company Info

1988 - The Company was incorporated as Public Limited Company on 16th March with the ROC and obtained the certificate of commencement of business on 7th of April. - The Hospital has 4 cardio-thoracic surgery operation theatres (OTs), 2 neurosurgery OTs, 5 major OTs, 4 minor OTs, 2 emergency OTs and 1 maternity OT. These OTs are being used for the various specialties/services that are available in the hospital. 1990 - The Company entered into an agreement with Indian Hospital Corporation Limited on 17th July. IHCL is providing technical consultancy and project consultancy for setting up, commissioning and functioning of the hospital. - The Company has also installed 2 DG sets of 750 KVA capacity each as standby arrangements. - Three steam boilers with a capacity of 2000 kg/hr each with requisite storage and distribution systems have been installed to meet the requirement of steam. 1992 - The company entered into an agreement with MCS Ltd for redressal of investor grievances for a period of six months from the last date of dispatch of letter of allotment advice/share certificates/refund orders. 1996 - The Cardiology and Cardiothoracic Surgery have state-of-the-art facilities for cardiac care and treatment. 3 Catheterisation laboratores with Digital imaging & electrophysiology facilities have been set-up. - The Neuro Sciences department is one of the few centres in Asia providing advanced neuro surgery facilities. - Since August, 300 beds have been commissioned with an average occupancy of 200 beds. - The Company is setting up "Indraprastha Apollo Hospitals" a 695 bed multi-disciplinary super specialty tertiary care hospital with state of the art facilities at a site on Delhi-Mathura Road, near Sarita Vihar, New Delhi. - The Company proposes to set-up satellite centres in strategic locations in and around Delhi which will have 8-10 consultancy rooms and basic diagnostic facilities. - An Incinerator with a capacity of 125 kgs per hour has been installed for disposal of combustible waste, infectious waste, human tissue, bandage, dressing linen etc. - IMCL has installed compressors for compressed air and medical gases. - The Company has entered into an equipment lease agreement with IHCL for leasing of specified medical equipment. 1997 - Indraprastha Medical Corporation Limited is entering the capital market with a public issue of 2,29,18,900 equity shares of Rs.10 each for cash at par aggregating to Rs.22,91,83,000. - Indraprastha Medical Corporation is a multi-speciality 600-bed corporate hospital being set up in New Delhi. Besides the hospital complex the corporate hospital also has plans to set up five satellite centres. - The first joint sector venture in healthcare in the country was set up in collaboration with NCT (National Capital Territory) of Delhi, bringing together the strategic focus and operational advantages of the private sector. 1998 - Recently, a combined team of cardiologists and neurologists successfully developed a new technique of safely embolizing septal artery without affecting vital circulation of the rest of the heart muscle. The hardware was a combination of material used in coronary angioplasty and cerebral AVM repairs. This procedure has been performed for the first time in the world. - A new technique "thrombolysis" devised by the neuroradiology unit to treat early stroke victims involves injection of a special medicine directly into the clot within an artery in the brain to dissolve it. - Palliative Medicine, for the first time in the country, being offered as a dedicated speciality service by the hospital, is a concept of medical care that provides for people who are terminally ill. - The Assisted Reproductive Unit comprising a team of highly skilled and experienced specialists trained in the UK and USA has been commissioned. - Eight national and international conferences held with renowned faculty drawn from across ten countries, most important of them being OPTIMA 98 - a 3-day international conference conducted by the Department of Neurosciences, being the first of its kind in the country. - A six-month certificate course on Operation Theatre Technology and Tertiary Nursing Care for qualified registered nurses graduated from various institutions commences 1 July, comprising two semesters each of clinical and theoretical practice. - The hospital is one of the multicenteric multinational drug trial centres for drug control studies for hypertension. - The hospital is now on the internet with the most comprehensive website with, inter alia, an animated walkthru of the hospital, facility for online appointments and updates on all available services. 1999 - The group also has an ambitious plan of setting up hospitals in Ludhiana, Lucknow, Ahmedabad, Vizag and possibly Calcutta and Mumbai. Abroad, after Dubai and Muscat, the company is looking at East Africa and Sri Lanka and Bangladesh. - The Apollo Hospitals group has no immediate plans to include its Delhi-based associate company -- Indraprastha Medical Corporation Ltd (IMCL) -- in the on-going consolidation process involving merger of the remanning three group companies into single entity. - Besides the Delhi Government, IMCL has been promoted by Dr. Reddy and Shrodders Ventures of the UK who together hold 49 per cent stake in the company. The public holds a 25 per cent stake in IMCL. - The agreement entered into between the promoters in 1998 gives an option to the Delhi Government to divest its 26 per cent stake in IMCL in three tranches once the Indraprastha Apollo Hospital becomes fully operational. The stake has to be divested at a pre-determined compounded rate or the prevailing market price, whichever is higher. 2003 -M/s Vasudeva & Co. has been appointed as the Auditors of the company. 2005 -Delist from The Delhi Stock Exchange Association Limited w.e.f. January 20, 2005. 2008 -Indraprastha Medical Corporation Ltd has appointed Shri. Rakesh Mehta, Chief Secretary, Govt. of NCT of Delhi as an Additional Director and Chairman of the Board of Directors of the Company. 2009 -Indraprastha Medical Corporation Ltd has recommended the payment of dividend @ 15% i.e. Rs. 1.50per share. 2010 -Indraprastha Medical Corporation Ltd has recommended the payment of dividend @ 16% i.e. Rs. 1.60per share. 2011 -Indraprastha Medical Corporation Ltd as a part of the expansion plan undertaken by the Company, 50 additional beds have been commissioned in the Hospital. -Indraprastha Medical has recommended the payment of dividend @ 16% i.e. Rs. 1.60 per share 2012 -Indraprastha Medical has recommended the payment of dividend @ 16% i.e. Rs. 1.60 per share 2013 -Indraprastha Medical Corporation Ltd has recommended the payment of dividend @ 16% i.e.Rs. 1.60 per share. -Indraprastha Medical Corporation Ltd have appointed Ms. Archana Arora Principal Secretary (Finance / Planning), Govt. of NCT of Delhi as an Additional Director of the Company. 2014 -Indraprastha Medical Corporation Ltd has recommended a dividend @ 18% (Rs. 1.80 per share). -Indraprastha Medical Corporation Ltd have appointed Mr. D. M. Spolia - Chief Secretary, Govt. of NCT of Delhi, as an Additional Director and Chairman of the Board of Directors of the Company. -Indraprastha Medical Corporation Ltd have appointedMs. Vineeta Rai as an Additional Director of the Company.

1988 - The Company was incorporated as Public Limited Company on 16th March with the ROC and obtained the certificate of commencement of business on 7th of April. - The Hospital has 4 cardio-thoracic surgery operation theatres (OTs), 2 neurosurgery OTs, 5 major OTs, 4 minor OTs, 2 emergency OTs and 1 maternity OT. These OTs are being used for the various specialties/services that are available in the hospital. 1990 - The Company entered into an agreement with Indian Hospital Corporation Limited on 17th July. IHCL is providing technical consultancy and project consultancy for setting up, commissioning and functioning of the hospital. - The Company has also installed 2 DG sets of 750 KVA capacity each as standby arrangements. - Three steam boilers with a capacity of 2000 kg/hr each with requisite storage and distribution systems have been installed to meet the requirement of steam. 1992 - The company entered into an agreement with MCS Ltd for redressal of investor grievances for a period of six months from the last date of dispatch of letter of allotment advice/share certificates/refund orders. 1996 - The Cardiology and Cardiothoracic Surgery have state-of-the-art facilities for cardiac care and treatment. 3 Catheterisation laboratores with Digital imaging & electrophysiology facilities have been set-up. - The Neuro Sciences department is one of the few centres in Asia providing advanced neuro surgery facilities. - Since August, 300 beds have been commissioned with an average occupancy of 200 beds. - The Company is setting up "Indraprastha Apollo Hospitals" a 695 bed multi-disciplinary super specialty tertiary care hospital with state of the art facilities at a site on Delhi-Mathura Road, near Sarita Vihar, New Delhi. - The Company proposes to set-up satellite centres in strategic locations in and around Delhi which will have 8-10 consultancy rooms and basic diagnostic facilities. - An Incinerator with a capacity of 125 kgs per hour has been installed for disposal of combustible waste, infectious waste, human tissue, bandage, dressing linen etc. - IMCL has installed compressors for compressed air and medical gases. - The Company has entered into an equipment lease agreement with IHCL for leasing of specified medical equipment. 1997 - Indraprastha Medical Corporation Limited is entering the capital market with a public issue of 2,29,18,900 equity shares of Rs.10 each for cash at par aggregating to Rs.22,91,83,000. - Indraprastha Medical Corporation is a multi-speciality 600-bed corporate hospital being set up in New Delhi. Besides the hospital complex the corporate hospital also has plans to set up five satellite centres. - The first joint sector venture in healthcare in the country was set up in collaboration with NCT (National Capital Territory) of Delhi, bringing together the strategic focus and operational advantages of the private sector. 1998 - Recently, a combined team of cardiologists and neurologists successfully developed a new technique of safely embolizing septal artery without affecting vital circulation of the rest of the heart muscle. The hardware was a combination of material used in coronary angioplasty and cerebral AVM repairs. This procedure has been performed for the first time in the world. - A new technique "thrombolysis" devised by the neuroradiology unit to treat early stroke victims involves injection of a special medicine directly into the clot within an artery in the brain to dissolve it. - Palliative Medicine, for the first time in the country, being offered as a dedicated speciality service by the hospital, is a concept of medical care that provides for people who are terminally ill. - The Assisted Reproductive Unit comprising a team of highly skilled and experienced specialists trained in the UK and USA has been commissioned. - Eight national and international conferences held with renowned faculty drawn from across ten countries, most important of them being OPTIMA 98 - a 3-day international conference conducted by the Department of Neurosciences, being the first of its kind in the country. - A six-month certificate course on Operation Theatre Technology and Tertiary Nursing Care for qualified registered nurses graduated from various institutions commences 1 July, comprising two semesters each of clinical and theoretical practice. - The hospital is one of the multicenteric multinational drug trial centres for drug control studies for hypertension. - The hospital is now on the internet with the most comprehensive website with, inter alia, an animated walkthru of the hospital, facility for online appointments and updates on all available services. 1999 - The group also has an ambitious plan of setting up hospitals in Ludhiana, Lucknow, Ahmedabad, Vizag and possibly Calcutta and Mumbai. Abroad, after Dubai and Muscat, the company is looking at East Africa and Sri Lanka and Bangladesh. - The Apollo Hospitals group has no immediate plans to include its Delhi-based associate company -- Indraprastha Medical Corporation Ltd (IMCL) -- in the on-going consolidation process involving merger of the remanning three group companies into single entity. - Besides the Delhi Government, IMCL has been promoted by Dr. Reddy and Shrodders Ventures of the UK who together hold 49 per cent stake in the company. The public holds a 25 per cent stake in IMCL. - The agreement entered into between the promoters in 1998 gives an option to the Delhi Government to divest its 26 per cent stake in IMCL in three tranches once the Indraprastha Apollo Hospital becomes fully operational. The stake has to be divested at a pre-determined compounded rate or the prevailing market price, whichever is higher. 2003 -M/s Vasudeva & Co. has been appointed as the Auditors of the company. 2005 -Delist from The Delhi Stock Exchange Association Limited w.e.f. January 20, 2005. 2008 -Indraprastha Medical Corporation Ltd has appointed Shri. Rakesh Mehta, Chief Secretary, Govt. of NCT of Delhi as an Additional Director and Chairman of the Board of Directors of the Company. 2009 -Indraprastha Medical Corporation Ltd has recommended the payment of dividend @ 15% i.e. Rs. 1.50per share. 2010 -Indraprastha Medical Corporation Ltd has recommended the payment of dividend @ 16% i.e. Rs. 1.60per share. 2011 -Indraprastha Medical Corporation Ltd as a part of the expansion plan undertaken by the Company, 50 additional beds have been commissioned in the Hospital. -Indraprastha Medical has recommended the payment of dividend @ 16% i.e. Rs. 1.60 per share 2012 -Indraprastha Medical has recommended the payment of dividend @ 16% i.e. Rs. 1.60 per share 2013 -Indraprastha Medical Corporation Ltd has recommended the payment of dividend @ 16% i.e.Rs. 1.60 per share. -Indraprastha Medical Corporation Ltd have appointed Ms. Archana Arora Principal Secretary (Finance / Planning), Govt. of NCT of Delhi as an Additional Director of the Company. 2014 -Indraprastha Medical Corporation Ltd has recommended a dividend @ 18% (Rs. 1.80 per share). -Indraprastha Medical Corporation Ltd have appointed Mr. D. M. Spolia - Chief Secretary, Govt. of NCT of Delhi, as an Additional Director and Chairman of the Board of Directors of the Company. -Indraprastha Medical Corporation Ltd have appointedMs. Vineeta Rai as an Additional Director of the Company.

Read More

Parent Organisation

Indraprastha Medical Corporation Ltd.

Founded

16/03/1988

Managing Director

Mr.Pattabhiraman Shivakumar

NSE Symbol

INDRAMEDCOEQ

FAQ

The current price of Indraprastha Medical Corporation Ltd is ₹ 419.20.

The 52-week high for Indraprastha Medical Corporation Ltd is ₹ 427.00 and the 52-week low is ₹ 416.15.

The market capitalization of Indraprastha Medical Corporation Ltd is currently ₹ 3842.93. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Indraprastha Medical Corporation Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Indraprastha Medical Corporation Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Indraprastha Medical Corporation Ltd shares.

The CEO of Indraprastha Medical Corporation Ltd is Mr.Pattabhiraman Shivakumar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT